Amcol International Corp. announced that its subsidiary Health & Beauty Solutions Inc. has acquired Microsponge technology from Cardinal Health's Pharmaceutical Technology and Services segment.
Microsponge is a system of biologically inert particles that are used to deliver active ingredients in dermatological products such as lotions and ointments.
According to Amcol, HBS will assume control of the technology and all related assets. Since 2003, HBS has supplied the product line to Cardinal under an exclusive supply agreement. HBS reportedly will continue to supply the line for limited purposes. Financial terms of the transaction have not been disclosed.